OUR RESEARCH

At Nanotreat Inc., our current research focuses on developing innovative solutions to combat infectious diseases through advanced nanoparticle technology. We are dedicated to exploring and optimizing lipid nanoparticle formulations that can effectively inhibit a wide range of airborne pathogens, including emerging viruses. Our research aims to enhance the delivery and efficacy of nasal sprays that serve as a first line of defense against infections like SARS-CoV-2.

By leveraging our expertise in nanotechnology and collaborating with leading scientists and institutions, we are pushing the boundaries of what is possible in infectious disease prevention. Our studies are designed to not only address current public health challenges but also anticipate future threats. We are committed to translating our research into practical, accessible treatments that can be rapidly deployed to protect global populations. Through our ongoing research efforts, Nanotreat is at the forefront of creating next-generation solutions for safeguarding public health against infectious diseases.